Today, April 7th, 2026, is World Health Day. The theme this year, ‘Together for health. Stand with science’ recognises the importance of scientific advancements and collaboration, and the importance of evidence, facts and science-based solutions to improving health.

In honour of this day, the Jreissati Pancreatic Centre at Epworth would like to shine a spotlight on our growing research portfolio.

Currently, the Centre has 45 active research projects and clinical trials, with several others under review. These range from sponsor-led interventional clinical trials testing new treatments for pancreatic cancer, to biobanks, registries, investigator-led collaborative trials and observational studies.

Some notable examples include the AMPLICITY trial, a study in metastatic pancreatic cancer patients involving a focal adhesion kinase (FAK) inhibitor delivered in combination with chemotherapy; the AP601 trial, a trial involving the assessment of a bi-specific antibody in the treatment of unresectable pancreatic cancer; the FMT study, a trial assessing co-treatment with faecal microbiota transplantation and chemotherapy; and finally the APRISE study, a screening program for individuals at high risk of developing pancreatic cancer.

The Jreissati Pancreatic Centre at Epworth is proud to collaborate with researchers and clinicians across Australia and internationally, in the scientific advancement of pancreatic cancer treatment and the fight to improve survival and quality of life.

To find a clinical trial or research study for yourself, your loved one or your patient, go to: Find a Clinical Trial and Research

Further information